Navigation Links
Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
Date:12/7/2010

is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials and submitted the AZ-004 NDA in December 2009.  In October 2010, the Company received a CRL from the FDA, regarding its NDA for AZ-004.  A CRL is issued by FDA's Center for Drug Evaluation and Research indicating that the NDA review cycle is complete and the application is not ready for approval in its present form.  The Company is currently evaluating the FDA's comments in the CRL and has scheduled a meeting with the FDA in December 2010 to discuss the CRL.

For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

This press release includes forward-looking statements regarding the development and safety of the Company's product candidates and technologies.  Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Se
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , September 2, 2014 ... Genetics has become the first European company to obtain ... Generation Sequencing (NGS) bioinformatic pipeline for routine genetic testing. ... in raising the standards of routine genetic testing ... Data Driven Medicine platform to a wider market. ...
(Date:9/2/2014)... Biotech Ltd. (NASDAQ: SVA ), a leading provider ... announced that the Company,s management will participate in the following ... Healthcare Conference, to be held at the Grand Hyatt New ... Stanley Asia Pacific Healthcare Day, to be held at the ... Healthcare & Technology Conference, to be held at the Wynn ...
(Date:9/2/2014)... , Sept. 2, 2014 Legal-Bay LLC, ... increase in capital and cash advance funding for ... System,s da Vinci Robot. With over 400k surgeries ... focuses on providing lawsuit cash advances for victims ... damage, lacerations to internal organs, burns to blood ...
Breaking Medicine Technology:Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing 2Sinovac to Participate in Upcoming Investor Conferences 2da Vinci Lawsuit Settlement Funding Amounts Increased at Legal-Bay Funding 2da Vinci Lawsuit Settlement Funding Amounts Increased at Legal-Bay Funding 3
... 7, 2011 Reportlinker.com announces that a new ... The 2011 Top Ten ... http://www.reportlinker.com/p0368704/The-2011-Top-Ten-World,s-Leading-Pharmaceutical-Companies.html A thought-provoking report ... major competitors in the worldwide pharmaceutical market. The ...
... 7, 2011 Reportlinker.com announces that a ... its catalogue: Aesthetic Devices ... be Driven by Improving Treatment Outcomes and ... http://www.reportlinker.com/p0409144/Aesthetic-Devices-Market-to-2017---Future-Growth-to-be-Driven-by-Improving-Treatment-Outcomes-and-Increase-in-Consumer-Confidence.html Aesthetic ...
Cached Medicine Technology:Reportlinker Adds The 2011 Top Ten World's Leading Pharmaceutical Companies 2Reportlinker Adds Aesthetic Devices Market to 2017 - Future Growth to be Driven by Improving Treatment Outcomes and Increase in Consumer Confidence 2Reportlinker Adds Aesthetic Devices Market to 2017 - Future Growth to be Driven by Improving Treatment Outcomes and Increase in Consumer Confidence 3
(Date:9/2/2014)... 2014 Splashtop Inc. , the ... with NTT DoCoMo to deliver Splashtop Business ... Business Lite is included in NTT DoCoMo’s “Business Plus” ... software that empower users to remote access their corporate ... over 18 million users worldwide. Splashtop delivers the ...
(Date:9/2/2014)... West Hollywood cosmetic dentist , ... Invisalign. This special offer includes a free consultation in ... their candidacy for the procedure and answer any questions ... also be eligible for the Summer Invisalign special, which ... month of August, patients who choose Invisalign will receive ...
(Date:9/2/2014)... Dennis Thompson HealthDay ... Babies born early or at low birth weight are at ... or health problems that increase their risk for heart disease, ... though these children face potential lifetime disadvantages, researchers in ... -- found that these obstacles can be overcome. ...
(Date:9/2/2014)... 02, 2014 Moroccan Eco-Biologics’ new one-of-a-kind ... formulated, while preserving the foundation of all natural Moroccan ... and scalp problems. There is nothing similar to Vitality ... , Hair loss is a commonly encountered problem for ... for treatment have been limited to existing medications offering ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 USARAD ... teleradiology and telemedicine solutions provider, including SecondOpinions.com® – ... innovative and technologically advanced services. The telemedicine industry ... Hospital in Kuwait. , Founded and established in ... Dar Al Shifa began as a maternity care ...
Breaking Medicine News(10 mins):Health News:Splashtop and NTT DoCoMo Partner to Deliver “Splashtop Business Lite” Secure Remote Access Solution to Business Customers 2Health News:West Hollywood Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Complimentary Consultations for Invisalign 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 3Health News:New All Natural, Organic Hair Recovery Products by Moroccan Eco-Biologics, Restore Lost Hair with No Side Effects 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 4
... 19 (HealthDay News) -- More than 40 percent of cancer ... and female patients, finds a new study. Researchers at ... cancer survivors and found that 43 percent had experienced pain ... at least two years later. Among white patients, ...
... Physical Review X (PRX), an online, open access, ... As broad in scope as physics itself, PRX will ... and will be of value to the global multidisciplinary readership. ... and an open access venue in accord with the strong ...
... boys and girls who are victims of bullying, including bullying ... depression. However, according to a new study, adolescent girls may ... As schools reopen following the holidays, the message ... serious consequences:"If your daughter is a victim of bullying, take ...
... may have good reason to be concerned about how ... new video games since the holidays. A new study ... State University psychologist -- found further evidence that video ... gaming, lower social competence and greater impulsivity were risk ...
... Scientists around the world have been hot on the ... cancers and leukemia since the mutation,s discovery in 2008. The ... issue of Cancer Cell , researchers reveal how the ... counter its effects. About 75 percent of people with ...
... University of Stavanger,s Reading Centre asks if something is lost ... to keyboard. The process of reading and writing involves ... our brain receives feedback from our motor actions, together with ... of feedback is significantly different from those we receive when ...
Cached Medicine News:Health News:1 in 5 Cancer Survivors Suffers Chronic Pain, Study Finds 2Health News:American Physical Society announces Physical Review X 2Health News:Girls who are bullied are at risk for substance use through depression 2Health News:New Pediatrics study identifies the risks, consequences of video game addiction 2Health News:New Pediatrics study identifies the risks, consequences of video game addiction 3Health News:Molecular battle in cancer cells offers clues for treatment 2Health News:Better learning through handwriting 2Health News:Better learning through handwriting 3
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
... Services is a Web-based and RFID-enabled location ... and measure patient flow and utilization of ... to discharge. AgileTrac collects patient information including ... your patient might experience. This information is ...
... To the network of door controllers, ... regular intervals throughout the coverage area. These ... Pulsing tags. Although similar in size and ... tag used with RoamAlert ECO and RoamAlert ...
... positioning solution (IPS) enables ... and when equipment, staff ... care processes. This time-stamped ... that hospitals can use ...
Medicine Products: